Search research articles
Contact Us
Filters
Showing results (81-90 of 106) with videos related to
Page
of 11
Sort By:
Diabetes Care
|
December 6, 2023
High Mannose Correlates With Surrogate Indexes of Insulin Resistance and Is Associated With an Increased Risk of Cardiovascular Events Independently of Glycemic Status and Traditional Risk Factors
Elena Fortin, Beatrice Campi, Ele Ferrannini, et al.
Journal of Diabetes and Its Complications
|
September 8, 2023
Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial
Viveca Ritsinger, Emil Hagström, Kristina Hambraeus, et al.
European Journal of Heart Failure
|
June 16, 2021
Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden)
Gianluigi Savarese, Johan Bodegard, Anna Norhammar, et al.
Diabetes Research and Clinical Practice
|
November 6, 2022
SOdium-glucose CO-transporter inhibition in patients with newly detected Glucose Abnormalities and a recent Myocardial Infarction (SOCOGAMI)
Magnus Lundin, Giulia Ferrannini, Linda Mellbin, et al.
Scandinavian Cardiovascular Journal : SCJ
|
August 17, 2022
Long-term prognosis after a first myocardial infarction: eight years follow up of the case-control study PAROKRANK
Giulia Ferrannini, Mariam Almosawi, Kåre Buhlin, et al.
Cardiovascular Diabetology
|
February 12, 2021
Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys
Giulia Ferrannini, Dirk De Bacquer, Pieter Vynckier, et al.
Diabetes Care
|
June 30, 2022
Measures of Insulin Resistance as a Screening Tool for Dysglycemia in Patients With Coronary Artery Disease: A Report From the EUROASPIRE V Population
Giulia Ferrannini, Dirk De Bacquer, Iris Erlund, et al.
Cardiovascular Diabetology
|
March 5, 2025
Aortic valve calcification across stages of dysglycemia in middle-aged individuals from the general population
Anne Wang, Carl Johan Östgren, Anna Norhammar, et al.
Diabetes, Obesity & Metabolism
|
February 19, 2021
Association of sodium-glucose cotransporter-2 inhibitors with outcomes in type 2 diabetes with reduced and preserved left ventricular ejection fraction: Analysis from the CVD-REAL 2 study
Carolyn S P Lam, Avraham Karasik, Cheli Melzer-Cohen, et al.
Diabetes, Obesity & Metabolism
|
December 12, 2018
How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study
Kåre I Birkeland, Johan Bodegard, Anna Norhammar, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 106) with videos related to
Sort By:
Page
of 11
Diabetes Care
|
December 6, 2023
High Mannose Correlates With Surrogate Indexes of Insulin Resistance and Is Associated With an Increased Risk of Cardiovascular Events Independently of Glycemic Status and Traditional Risk Factors
Elena Fortin, Beatrice Campi, Ele Ferrannini, et al.
Journal of Diabetes and Its Complications
|
September 8, 2023
Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial
Viveca Ritsinger, Emil Hagström, Kristina Hambraeus, et al.
European Journal of Heart Failure
|
June 16, 2021
Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden)
Gianluigi Savarese, Johan Bodegard, Anna Norhammar, et al.
Diabetes Research and Clinical Practice
|
November 6, 2022
SOdium-glucose CO-transporter inhibition in patients with newly detected Glucose Abnormalities and a recent Myocardial Infarction (SOCOGAMI)
Magnus Lundin, Giulia Ferrannini, Linda Mellbin, et al.
Scandinavian Cardiovascular Journal : SCJ
|
August 17, 2022
Long-term prognosis after a first myocardial infarction: eight years follow up of the case-control study PAROKRANK
Giulia Ferrannini, Mariam Almosawi, Kåre Buhlin, et al.
Cardiovascular Diabetology
|
February 12, 2021
Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys
Giulia Ferrannini, Dirk De Bacquer, Pieter Vynckier, et al.
Diabetes Care
|
June 30, 2022
Measures of Insulin Resistance as a Screening Tool for Dysglycemia in Patients With Coronary Artery Disease: A Report From the EUROASPIRE V Population
Giulia Ferrannini, Dirk De Bacquer, Iris Erlund, et al.
Cardiovascular Diabetology
|
March 5, 2025
Aortic valve calcification across stages of dysglycemia in middle-aged individuals from the general population
Anne Wang, Carl Johan Östgren, Anna Norhammar, et al.
Diabetes, Obesity & Metabolism
|
February 19, 2021
Association of sodium-glucose cotransporter-2 inhibitors with outcomes in type 2 diabetes with reduced and preserved left ventricular ejection fraction: Analysis from the CVD-REAL 2 study
Carolyn S P Lam, Avraham Karasik, Cheli Melzer-Cohen, et al.
Diabetes, Obesity & Metabolism
|
December 12, 2018
How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study
Kåre I Birkeland, Johan Bodegard, Anna Norhammar, et al.
Page
of 11